Group 1 - The company plans to raise RMB 500 million through the issuance of H-shares to acquire a 99.99% stake in Yangzhong Xingfu Jiayuan Venture Capital Partnership, increasing its total subscribed capital to approximately RMB 400 million [1][2] - The partnership will focus on investments in emerging industries such as integrated circuits and artificial intelligence, particularly in the optical devices, chips, and core IC sectors, targeting early-stage and growth-stage companies [1][2] - The partnership will also have the ability to invest in high-quality overseas technology companies and allocate overseas assets, while funds during idle periods can be invested in various cash management tools recognized by the China Securities Regulatory Commission [1][2] Group 2 - This investment allows the company to leverage the resources and advantages of professional institutions in the investment field, aiming for medium to long-term investment returns while controlling risks [2] - By focusing on the optical devices, chips, and core IC sectors, the company aims to enhance its control over the upstream and downstream of the industry chain, improve technical capabilities, and increase market coverage and influence [2] - The investment strategy aligns with the company's long-term development strategy and fundraising plans, diversifying the investment portfolio and maximizing strategic and operational synergies [2]

本次投资是公司使用发行境外上市外资股(H 股)募集资金与专业机构共同进行的投资，能够充分利用专 业机构在投资领域的资源和优势，在合理控制风险的前提下，开展股权投资业务，以获取中长期投资回 报。同时，通过重点布局光器件、芯片及核心 IC 领域企业，能够加强公司对产业链上下游的掌控力， 提升公司的技术能力和供应链韧性，提高下游市场覆盖率和扩大市场影响力，多样化公司的投资组合及 最大化战略及经营协同效应，符合公司长远发展战略及募集资金使用规划。 智通财经APP讯，剑桥科技(06166)公布，公司拟以发行境外上市外资股(H 股)募集资金人民币 500 万元 受让陈璐持有的扬中幸福家园创业投资合伙企业(有限合伙)(以下简称"合伙企业")99.99%的财产份额(对 应认缴份额1亿元，已实缴出资 500 万元)，并作为有限合伙人以发行境外上市外资股(H股)募集资金增 加认缴份额3亿元。本次交易完成后，合伙企业认缴出资总额变更为约人民币4亿元，公司认缴出资4亿 元，占比99.9975%，合伙企业将纳入公司合并报表范围。 合伙企业的投资标的是集成电路、人工智能等先进制造、信息技术类新兴行业的未上市/挂牌成长性、 创新性企业，重 ...

Group 1: Resumption and Suspension of Trading - Tailong Pharmaceutical's controlling shareholder has reached an agreement with relevant parties regarding a potential change in company control, leading to the resumption of trading [1] - Puran Co. plans to acquire a 49% stake in high-performance memory company Noah Changtian, resulting in the resumption of trading [2] - Pianao's controlling shareholder, Ma Libin, is planning matters related to a potential change in actual control, leading to the suspension of trading [2] Group 2: Mergers and Acquisitions - Weidi Co. intends to acquire a 51% stake in Jiangsu Jiuxing Precision Technology through a cash payment [3] - Honghua Digital Technology plans to acquire a 49% stake in Shandong Yingkejie Digital Technology for 105 million yuan [4] Group 3: Equity Transfer and Buyback - Shaanxi Natural Gas Group is transferring 7% of the company shares and Huaitong Capital is transferring 6% [4] - Hailunzhe plans to repurchase company shares worth between 50 million and 100 million yuan [5] Group 4: External Investment and Daily Operations - Cambridge Technology plans to increase capital by 100 million USD to its wholly-owned subsidiary CIG USA to expand high-speed optical module production capacity in North America and Southeast Asia [6] - Zhejiang Rongtai intends to invest approximately 545 million yuan in Thailand to build a production project with an annual output of 14,000 tons of mica paper, 4,500 tons of mica products, and 7 million sets of robot components [6] - Nenghui Technology has signed a framework contract for 350 MWh energy storage and the first batch of sales contracts with a European company [7] - Lizhong Group has signed a procurement agreement for 5,000 humanoid robot processing parts with Weijing Intelligent [8] - Guoxin Technology has successfully completed internal testing of a new anti-quantum password financial POS machine chip [9] - Changchun Gaoxin's subsidiary Jin Sai Pharmaceutical has developed a new product, Jin Sai Zeng, which has been included in the national medical insurance directory [9] - Shengda Resources plans to acquire a 60% stake in Jinshi Mining for 500 million yuan [10] - Aerospace Rainbow and its affiliate Zhongtian Rocket will jointly invest 50 million yuan to establish a subsidiary in Xinjiang [11] - Ganli Pharmaceutical's wholly-owned subsidiary has received a clinical trial approval notice from the National Medical Products Administration for the investigational drug GLR1044 injection [11]

剑桥科技（603083）(06166)公布，CIG美国作为落实发行H股募资投向的重要实施主体之一，将在研发 投入、业务扩展、客户服务、全球化产能配套及供应链协同方面发挥重要作用。为支持CIG美国的上述 业务部署，提升此次境外发行募集资金的利用效率，公司拟以发行境外上市外资股(H股)募集资金向 CIG美国增资1亿美元，用于：(1)采购配套生产设备，扩张公司在北美及东南亚地区高速光模块产能配 套，提升全球交付能力;(2)提升海外研发规模和能力，加速新技术和新产品的开发及技术迭代，确保公 司产品的技术领先性;(3)加大市场营销力度，拓展重点市场和客户，构建销售渠道和客户服务体系，支 撑业务长期高速成长;(4)加大关键元器件的战略性采购和储备力度，稳定并增强核心元器件的供应能 力，确保交付的稳定及高速增长;(5)参与产业链协同，通过战略性合作提升全球供应链安全;(6)补充运营 资金。 ...

Core Viewpoint - Cambridge Technology (06166) plans to raise $100 million through the issuance of H-shares to enhance CIG America’s capabilities in R&D, business expansion, customer service, globalization, and supply chain collaboration [1] Funding Utilization - The $100 million raised will be allocated to several key areas: - Procurement of production equipment to expand high-speed optical module capacity in North America and Southeast Asia, enhancing global delivery capabilities [1] - Increasing overseas R&D scale and capabilities to accelerate the development and iteration of new technologies and products, ensuring technological leadership [1] - Strengthening marketing efforts to expand key markets and customers, building sales channels and customer service systems to support long-term high-speed growth [1] - Strategic procurement and reserve of key components to stabilize and enhance the supply capability of core components, ensuring stable and rapid delivery [1] - Participating in industry chain collaboration to enhance global supply chain security through strategic partnerships [1] - Supplementing operational funds to support ongoing business activities [1]

Group 1 - Cambridge Technology plans to invest 400 million yuan to establish a fund focused on optical devices and chips, aiming to invest in early-stage and growth-stage companies in the hard technology sector [1] - Tunnel Corporation's consortium won a bid for a highway project in Henan with a total investment of 6.49 billion yuan, using a BOT model for a 33.25-year cooperation period [2] - Hongrun Construction won a bid for a project worth 230 million yuan, which represents 3.88% of the company's projected revenue for 2024 [3] Group 2 - Tongrentang's product, Canling Baizhu Powder, received product registration approval from Health Canada, aimed at treating symptoms related to spleen and stomach weakness [4] - Hunan Baiyin announced a scheduled annual maintenance from December 9, 2025, to January 5, 2026, for equipment and facilities [5] - Changchun Gaoxin's subsidiary had two drugs included in the national medical insurance catalog for 2025 [6] Group 3 - Dongfang Securities' chairman resigned due to work relocation [7] - Xuantai Pharmaceutical's product, Sitagliptin Metformin Sustained-Release Tablets, was renewed for inclusion in the national medical insurance catalog [8] - ST Weihai was pre-selected for a smart agriculture EPC project with a bid of 652 million yuan, accounting for 26.27% of the company's projected revenue for 2024 [9] Group 4 - Guoxin Technology successfully tested an anti-quantum password financial POS chip, supporting both traditional and quantum-resistant algorithms [10] - Huaren Health's subsidiary received acceptance for a drug registration application for Lactulose Oral Solution, a common laxative [11] - Ankai Bus reported a 57.71% year-on-year increase in sales for the first 11 months of the year [12] Group 5 - Zhongyan Dadi's subsidiary won a bid for a project worth 73.86 million yuan [13] - Zhejiang Rongtai plans to invest 77 million USD in a factory in Thailand, focusing on mica paper and robot components production [14] - Optoelectronics plans to use up to 450 million yuan of idle funds for cash management [15] Group 6 - Tianyu Biological reported a 45.15% year-on-year decline in sales revenue from pig sales in November [16] - Daqin Railway's cargo transport volume increased by 1.75% year-on-year in November [17] - Yabo Co. won a bid for a heavy truck charging station project worth 3.616 million yuan [18] Group 7 - Hongri Pharmaceutical's product continues to be included in the national medical insurance catalog [19] - Jinggong Steel Structure signed a contract for steel structure installation worth approximately 470 million yuan for an overseas project [20] - Xizang Pharmaceutical's product, Xinhuasuan, continues to be included in the national medical insurance catalog [21] Group 8 - Guangdong Electric Power A announced the successful commissioning of a 1000MW unit at the Maoming Boge Power Plant [22] - Fuan Pharmaceutical's product, Palivizumab Injection, was newly included in the national medical insurance catalog [23] - Lizhu Group reported that 194 products were included in the 2025 national medical insurance catalog [24] Group 9 - Haisan Pharmaceutical's injection of Lantanol was included in the national medical insurance catalog [25] - Zhongtong Bus reported a 39.53% year-on-year increase in sales volume in November [26] - Shaanxi Coal Industry reported a 6.03% year-on-year increase in coal production in November [27] Group 10 - Haooubo's subsidiary received a medical device registration certificate for an IgG4 testing kit [28] - Yaopi Glass plans to invest 690 million yuan in new automotive glass production lines [30] - Huadian International completed the issuance of 2 billion yuan in medium-term notes [31] Group 11 - Zhongzai Zihuan's subsidiary won a bid for a green recycling project worth 205 million yuan [32] - Dabeinong reported a 25.26% year-on-year decline in sales revenue from pig sales in November [33] - Xiangjia Co. reported a 3.77% year-on-year increase in live poultry sales revenue in November [34] Group 12 - Huanxu Electronics reported a consolidated revenue of 5.198 billion yuan in November, a decrease of 3.34% year-on-year [35] - Aonong Biological reported a 72.21% year-on-year increase in pig sales volume in November [36] - Samsung Medical's subsidiary was pre-selected for a procurement project worth approximately 108 million yuan [37]

Core Insights - The F5G concept sector experienced a significant increase of 4.30%, ranking second among concept sectors, with 34 stocks rising, including Dongtian Microelectronics which hit a 20% limit up [1] - Major contributors to the rise included Huamai Technology, Tongyu Communication, and Dekeli, with respective increases of 10.02%, 10.01%, and 13.19% [1][2] - The sector saw a net inflow of 2.668 billion yuan from main funds, with 22 stocks receiving net inflows, and 10 stocks exceeding 100 million yuan in net inflows [1] Sector Performance - The F5G concept sector led the day's performance with a 4.30% increase, followed by other sectors such as Co-packaged Optics (4.72%) and Optical Fiber (3.67%) [1] - The top gainers in the F5G sector included Dongtian Microelectronics (20%), Huamai Technology (10.02%), and Tongyu Communication (10.01%) [1][3] - Conversely, the worst performers included Shanghai Port Group (-0.71%) and Tiandi Technology (-0.17%) [1] Fund Flow Analysis - The leading stocks in terms of net inflow ratio were Huamai Technology (28.70%), Tongyu Communication (21.24%), and Dongtian Microelectronics (12.71%) [2][3] - Huagong Technology topped the net inflow list with 554 million yuan, followed by Changxin Bochuang and Dekeli with 342 million yuan and 325 million yuan respectively [1][2] - The overall fund flow indicates strong investor interest in the F5G sector, with significant capital being directed towards key players [1][2]

12月8日晚间，剑桥科技（603083）公告称，公司拟以发行境外上市外资股(H股)募集资金向全资子公司 CIG美国增资1亿美元，用于采购配套生产设备，扩张公司在北美及东南亚地区高速光模块产能配套， 提升全球交付能力等。 对于三季度业务表现，在11月接受投资者调研时，剑桥科技表示，三季度该公司光模块业务增长表现尤 为突出，800G光模块持续推进扩产，产能逐步释放的同时发货量亦同步提升；传统业务(宽带、无线)保 持稳定增长态势，Wi-Fi7产品实际发货量表现可观。 一是采购配套生产设备，扩张剑桥科技在北美及东南亚地区高速光模块产能配套，提升全球交付能力； 二是提升海外研发规模和能力，加速新技术和新产品的开发及技术迭代，确保公司产品的技术领先性； 三是加大市场营销力度，拓展重点市场和客户，构建销售渠道和客户服务体系，支撑业务长期高速成 长；四是加大关键元器件的战略性采购和储备力度，稳定并增强核心元器件的供应能力，确保交付的稳 定及高速增长；五是参与产业链协同，通过战略性合作提升全球供应链安全；六是补充运营资金。 剑桥科技表示，将严格要求CIG美国遵循募集资金专项用途，不得将此次增资款项用于与主营业务无关 的支出。 ...

剑桥科技（603083）(603083.SH)发布公告，为支持CAMBRIDGE INDUSTRIES USA INC.(以下简 称"CIG美国")的业务部署，提升此次境外发行募集资金的利用效率，公司拟以发行境外上市外资股(H 股)募集资金向CIG美国增资1亿美元，用于采购配套生产设备，扩张公司在北美及东南亚地区高速光模 块产能配套等项目。 ...

本次投资是公司使用发行境外上市外资股(H股)募集资金与专业机构共同进行的投资，能够充分利用专 业机构在投资领域的资源和优势，在合理控制风险的前提下，开展股权投资业务，以获取中长期投资回 报。同时，通过重点布局光器件、芯片及核心IC领域企业，能够加强公司对产业链上下游的掌控力，提 升公司的技术能力和供应链韧性，提高下游市场覆盖率和扩大市场影响力，多样化公司的投资组合及最 大化战略及经营协同效应，符合公司长远发展战略及募集资金使用规划。 剑桥科技（603083）(603083.SH)发布公告，公司拟以发行境外上市外资股(H股)募集资金人民币500万 元受让陈璐持有的扬中幸福家园创业投资合伙企业(有限合伙)(以下简称"合伙企业")99.99%的财产份额 (对应认缴份额10,000万元，已实缴出资500万元)，并作为有限合伙人以发行境外上市外资股(H股)募集 资金增加认缴份额3亿元。本次交易完成后，合伙企业认缴出资总额变更为人民币40,001万元，公司认 缴出资40,000万元，占比99.9975%，合伙企业将纳入公司合并报表范围。 ...